Systemic Immune-Inflammation Index (SII) is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria

MLA

Hongyuan Fu, et al. “Systemic Immune-Inflammation Index (SII) Is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria.” Cellular Physiology and Biochemistry, vol. 47, no. 1, May 2018, pp. 293–301. EBSCOhost, https://doi.org/10.1159/000489807.

APA

Hongyuan Fu, Jun Zheng, Jianye Cai, Kaining Zeng, Jia Yao, Liang Chen, Hui Li, Jiebin Zhang, Yingcai Zhang, Hui Zhao, & Yang Yang. (2018). Systemic Immune-Inflammation Index (SII) is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria. Cellular Physiology and Biochemistry, 47(1), 293–301. https://doi.org/10.1159/000489807

Chicago

Hongyuan Fu, Jun Zheng, Jianye Cai, Kaining Zeng, Jia Yao, Liang Chen, Hui Li, et al. 2018. “Systemic Immune-Inflammation Index (SII) Is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria.” Cellular Physiology and Biochemistry 47 (1): 293–301. doi:10.1159/000489807.